Caleco Pharma Corp. (OTCBB: CAEH) has appointed Jim Metropoulos, MD, to their Product Development Advisory Board. The Board is responsible for guiding the development of their Over-The-Counter and prescription products from research stages through commercialization. Dr. Metropoulus has held senior executive healthcare communications and product commercialization for over 17 years.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
About Caleco Pharma Corp.
The Company's business plan is to develop its proprietary technology designed to treat moderate to severe liver maladies, including Hepatitis C viral infection, (the "Liver Health Formula") as an over-the-counter medication and as a United States Food and Drug Administration ("FDA") approved pharmaceutical. To date, the Company's intellectual property covering the Liver Health Formula is comprised of patent applications in the United States, Europe and Canada and four European Drug Master File applications.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
